Taurine vs Magnesium for Blood Pressure — which lowers it more?
Both taurine and magnesium have trial-level blood-pressure-lowering signals, but the effect sizes, responder profiles, and stacking logic are different. Taurine has the bigger systolic effect in pre-hypertensive and stage-1 hypertensive cohorts at 1.5–3 g/day. Magnesium has the smaller but more consistent effect, larger in magnesium-deficient subgroups. Neither replaces first-line antihypertensives; both can be useful adjuncts in mild disease or while a lifestyle plan is taking effect.
Quick verdict
| Scenario | Better choice | Why |
|---|---|---|
| Pre-hypertension (130–139 / 80–89) | Taurine | Sun 2016 meta-analysis: ~7 mmHg systolic reduction at 1.5–3 g/day. |
| Stage 1 hypertension on lifestyle | Taurine (with magnesium add-on) | Larger trial effect; magnesium can add another 2–3 mmHg. |
| Known magnesium deficiency / low intake | Magnesium | Effect is largest where intake is lowest; corrects an actual deficit. |
| Pregnancy-related elevated BP | Neither without OB guidance | Pregnancy hypertension is high-risk; first-line via obstetrics. |
| Resistant hypertension on 3+ drugs | Neither replaces titration / workup | Look for sleep apnoea, aldosteronism, renal disease. |
| Comorbid sleep / muscle complaints | Magnesium glycinate | Adjacent benefits make magnesium the higher-utility pick. |
How they actually work
Mechanism — natriuretic amino acid vs vascular relaxant
Taurine is a sulphur-containing amino acid abundant in skeletal and cardiac muscle. Its proposed blood-pressure mechanisms include modulation of central sympathetic tone, attenuation of angiotensin II signalling, improvement of endothelial nitric oxide availability, and modest natriuretic effects. Animal and small human studies suggest taurine particularly suppresses elevated sympathetic outflow — relevant in the "high-cardiac-output" hypertension phenotype.
Magnesium acts as a physiological calcium-channel modulator: vascular smooth muscle contraction depends on calcium entry, and magnesium sufficiency limits excessive vasoconstriction. Magnesium also supports endothelial function and modulates renin-angiotensin signalling. The 2017 Zhang meta-analysis (34 RCTs, 2028 participants) found magnesium supplementation lowered systolic BP by ~2 mmHg and diastolic by ~1.8 mmHg; the effect was larger in deficient cohorts.
Effect size by RCT meta-analysis
- Taurine, Sun 2016 (Hypertension): 1.6 g/day for 12 weeks in pre-hypertensive adults — systolic reduction ~7 mmHg, diastolic ~5 mmHg vs placebo.
- Taurine, Waldron 2018: Trial-level signals at 1.5–3 g/day in adults with stage 1 hypertension; effect concentrated in those with elevated sympathetic markers.
- Magnesium, Zhang 2017 meta-analysis: 34 RCTs, ~2 mmHg systolic and ~1.8 mmHg diastolic; larger in deficient subgroups.
- Magnesium, Dibaba 2017 in T2DM: Similar small magnitudes; cleaner signal in those with low baseline intake.
Dose
Taurine: 1.5–3 g/day in 1–2 divided doses. Trial midpoint is 1.5 g/day for 8–12 weeks. Most studied as a daily oral powder or capsule; the form sold in energy drinks (~1 g) is not a chronic dosing regimen.
Magnesium: 300–400 mg elemental magnesium per day, glycinate or citrate. Take with the largest meal; split if higher doses (above 400 mg) cause GI upset.
Safety
Taurine is well-tolerated. Cautions are limited: theoretical additive hypotensive effect with antihypertensives, and rare GI upset. The "taurine causes mania" claim from energy-drink case reports is not supported by clinical-grade taurine trials. Pregnancy data are limited at supplemental doses.
Magnesium is well-tolerated; loose stools at higher doses, particularly with citrate or oxide. Avoid in advanced kidney disease (eGFR <30) and on potassium-sparing diuretics without monitoring. Space 2 hours from antibiotics (tetracyclines, fluoroquinolones), bisphosphonates, and thyroid medication.
Cost
Taurine runs $0.10–0.30/day at 2 g doses. Magnesium glycinate runs $0.10–0.30/day at 300–400 mg elemental.
Things that out-perform supplements
- DASH-style diet: 8–14 mmHg systolic reduction in trial cohorts.
- Sodium restriction to <1500–2300 mg/day: 2–8 mmHg systolic reduction.
- Weight loss (≥5%): ~5 mmHg per 5 kg.
- Regular aerobic exercise: ~5–7 mmHg systolic.
- Alcohol reduction (in heavy drinkers): 4–10 mmHg systolic.
For stage 2 hypertension or established CV risk, antihypertensive drug therapy is first-line. Supplements are adjuncts to lifestyle, not substitutes for indicated medication.
What we'd actually do
For an adult with newly-noticed pre-hypertensive readings: start with home BP monitoring (proper cuff, 2 readings morning and evening for 7 days, average), DASH-style eating, sodium reduction, and weight goal if relevant. If supplementation is desired, taurine 1.5 g twice daily for 12 weeks with home BP tracking is the cleanest single-supplement test.
If dietary magnesium is low or adjacent complaints exist (poor sleep, muscle cramps, migraine, constipation), substitute magnesium glycinate 300–400 mg nightly — multi-purpose value beyond BP.
For confirmed hypertension or higher CV risk: this is a clinical conversation, not a supplement aisle.
Sources
- Sun Q, et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: randomized, double-blind, placebo-controlled study. Hypertension. 2016;67(3):541–549. PMID: 26781281
- Waldron M, et al. The effects of an oral taurine dose and supplementation period on endurance exercise performance in humans: a meta-analysis. Sports Med. 2018;48(5):1247–1253. PMID: 29546641
- Zhang X, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324–333. PMID: 27402922
- Dibaba DT, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017;106(3):921–929. PMID: 28724644
- Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13–e115. PMID: 29133356
- Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens. 2011;13(11):843–847. PMID: 22051430